{"id":"W4412727529","doi":"10.1007/s40257-025-00964-6","title":"Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Probity Medical Research; University of Toronto","funders":"AbbVie","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Discontinuation; Adverse effect; Internal medicine; Dermatology Life Quality Index; Randomized controlled trial; Severity of illness; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003555223,0.001401286,0.002152979,0.0002655114,0.0004889751,0.001735418,0.0009245027,0.001694418,0.004928063],"category_scores_gemma":[0.001962752,0.000481373,0.003000899,0.0002486498,0.00115477,0.001315618,0.0004042957,0.004657333,0.001604283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007691614,"about_ca_system_score_gemma":0.001187314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000723458,"about_ca_topic_score_gemma":0.001602763,"domain_scores_codex":[0.9991274,0.000381363,0.00004704614,0.0001379133,0.0001105294,0.0001957682],"domain_scores_gemma":[0.9987488,0.0003295919,0.0002442918,0.0001458854,0.0001078046,0.0004236054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8918378,0.0127667,0.002778527,0.001073388,0.00266648,0.0001425443,0.0002138871,0.001240818,0.01423601,0.0003481165,0.006231992,0.06646361],"study_design_scores_gemma":[0.8529768,0.128074,0.01088616,0.00008737399,0.00151586,0.0002537906,0.00008005885,0.000898843,0.001685967,0.0006212972,0.002871278,0.00004843725],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9813195,0.007476243,0.001084645,0.001283317,0.0004124065,0.001291805,0.002769128,0.0002453167,0.004117687],"genre_scores_gemma":[0.9864179,0.002354115,0.001599171,0.00173157,0.0003624769,0.001053233,0.003090397,0.00006246466,0.003328604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004928063,"threshold_uncertainty_score":0.01880205,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07167977802277621,"score_gpt":0.4016706240009211,"score_spread":0.3299908459781449,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}